Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease
Julien Chapuis(Inserm), Jean‐Charles Lambert(Inserm), Yves Lemoine(Institut Pasteur), Olivier Kerdraon(Inserm), Claudine Berr(Inserm), Ludovic Huot(Institut Pasteur), Philippe Amouyel(Institut Pasteur de Lille), Christine Hubans(Celescreen (France)), Luc Buée(Inserm), Fabienne Wavrant-DeVrièze(National Institutes of Health), Florence Pasquier, Stéphanie Ferreira(Celescreen (France)), Christophe Tzourio(The University of Sydney), Faïza Bensemain(Inserm), Nathalie Fiévet(Inserm), David Hot(Institut Pasteur), David M. A. Mann(Salford Royal NHS Foundation Trust), Franck Hansmannel(Inserm), Takeshi Iwatsubo(The University of Tokyo), Geoffroy Laumet(Michigan State University), M. Ilyas Kamboh(University of Pittsburgh), Steven T. DeKosky(University of Pittsburgh), C Lendon(QIMR Berghofer Medical Research Institute), Annick Alpérovitch(Inserm), J.F. Dartigues(Inserm), Anne‐Marie Ayral(Inserm), J J Hauw(Inserm), Claude‐Alain Maurage(Centre Hospitalier Universitaire de Lille)
Cited by 203
Related Papers
Lecanemab in Early Alzheimer’s Disease
|New England Journal of Medicine|2022|5k
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants
|The Lancet|2016|4.4k
New insights into the genetic etiology of Alzheimer’s disease and related dementias
|Nature Genetics|2022|2.5k
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
|Journal of Neuropathology & Experimental Neurology|2012|2.1k